AU2001268131A1 - Stabilized compositions containing oxygen-labile active agents - Google Patents
Stabilized compositions containing oxygen-labile active agentsInfo
- Publication number
- AU2001268131A1 AU2001268131A1 AU2001268131A AU6813101A AU2001268131A1 AU 2001268131 A1 AU2001268131 A1 AU 2001268131A1 AU 2001268131 A AU2001268131 A AU 2001268131A AU 6813101 A AU6813101 A AU 6813101A AU 2001268131 A1 AU2001268131 A1 AU 2001268131A1
- Authority
- AU
- Australia
- Prior art keywords
- active agents
- compositions containing
- containing oxygen
- stabilized compositions
- labile active
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/586,583 US6468552B1 (en) | 2000-06-02 | 2000-06-02 | Stabilized compositions containing oxygen-labile active agents |
US09586583 | 2000-06-02 | ||
PCT/US2001/017739 WO2001093816A2 (en) | 2000-06-02 | 2001-06-01 | Stabilized compositions containing oxygen-labile active agents |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001268131A1 true AU2001268131A1 (en) | 2001-12-17 |
Family
ID=24346337
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001268131A Abandoned AU2001268131A1 (en) | 2000-06-02 | 2001-06-01 | Stabilized compositions containing oxygen-labile active agents |
Country Status (4)
Country | Link |
---|---|
US (1) | US6468552B1 (en) |
EP (1) | EP1289490A2 (en) |
AU (1) | AU2001268131A1 (en) |
WO (1) | WO2001093816A2 (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2832630B1 (en) * | 2001-11-28 | 2005-01-14 | Oreal | COSMETIC AND / OR DERMATOLOGICAL COMPOSITION CONTAINING AT LEAST ONE OXIDATION-SENSITIVE HYDROPHILIC ACTIVE STABILIZED WITH AT LEAST ONE COPOLYMER OF N-VINYLIMIDAZOLE |
US20050042233A1 (en) * | 2003-08-21 | 2005-02-24 | Christopher Marrs | Stabilized compositions containing an oxygen-labile active agent and a fungal extract |
US20050042306A1 (en) * | 2003-08-21 | 2005-02-24 | Christopher Marrs | Stabilized compositions containing an oxygen-labile active agent |
KR20170102377A (en) | 2004-01-22 | 2017-09-08 | 유니버시티 오브 마이애미 | Topical co-enzyme q10 formulations and methodns of use |
WO2006065991A2 (en) * | 2004-12-17 | 2006-06-22 | Dr. Reddy's Laboratories Ltd. | Dispersion for delivering active agents |
EP1743624A1 (en) * | 2005-07-12 | 2007-01-17 | Johnson & Johnson Consumer France SAS | Silicone-in-water emulsion compositions containing retinoids |
US20070078180A1 (en) * | 2005-10-04 | 2007-04-05 | Kern Dale G | Methods and compositions for stabilizing an antioxidant |
US20070254947A1 (en) * | 2006-04-28 | 2007-11-01 | Rohto Pharmaceutical Co., Ltd. | Composition for external use |
BRPI0809164B8 (en) | 2007-03-22 | 2023-02-28 | Berg Llc | COMPOSITION FOR TOPICAL ADMINISTRATION AND PHARMACEUTICAL COMPOSITION COMPRISING SAID COMPOSITION |
WO2009126764A1 (en) | 2008-04-11 | 2009-10-15 | Cytotech Labs, Llc | Methods and use of inducing apoptosis in cancer cells |
FR2937866B1 (en) * | 2008-10-30 | 2010-11-26 | Natura Cosmeticos Sa | ANTIOXIDANT COMPLEX, COSMETIC AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAID COMPLEX AND THE USE OF SAID COMPLEX |
WO2010132502A2 (en) | 2009-05-11 | 2010-11-18 | Cytotech Labs, Llc | Methods for treatment of metabolic disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers |
WO2011112900A2 (en) * | 2010-03-12 | 2011-09-15 | Cytotech Labs, Llc | Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof |
AU2012240222B2 (en) | 2011-04-04 | 2017-04-27 | Berg Llc | Methods of treating central nervous system tumors |
EA201490047A1 (en) | 2011-06-17 | 2014-08-29 | Берг Ллк | INHALATION PHARMACEUTICAL COMPOSITIONS |
US10933032B2 (en) | 2013-04-08 | 2021-03-02 | Berg Llc | Methods for the treatment of cancer using coenzyme Q10 combination therapies |
EP3730131A1 (en) | 2013-09-04 | 2020-10-28 | Berg LLC | Methods of treatment of cancer by continuous infusion of coenzyme q10 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3755560A (en) | 1971-06-30 | 1973-08-28 | Dow Chemical Co | Nongreasy cosmetic lotions |
GB1541463A (en) | 1975-10-11 | 1979-02-28 | Lion Dentifrice Co Ltd | Process for prparing a multiple emulsion having a dispersing form of water-phase/oil-phase/water-phase |
US4421769A (en) | 1981-09-29 | 1983-12-20 | The Procter & Gamble Company | Skin conditioning composition |
US4549968A (en) | 1984-05-18 | 1985-10-29 | Betz Laboratories, Inc. | Method of utilizing improved stability oxygen scavenger compositions |
US4960764A (en) | 1987-03-06 | 1990-10-02 | Richardson-Vicks Inc. | Oil-in-water-in-silicone emulsion compositions |
US5559149A (en) | 1990-01-29 | 1996-09-24 | Johnson & Johnson Consumer Products, Inc. | Skin care compositions containing retinoids |
US5776438A (en) * | 1992-06-26 | 1998-07-07 | Shiseido Co., Ltd. | External preparation |
EP0608433B1 (en) | 1992-07-13 | 2004-05-19 | Shiseido Company, Ltd. | Composition for dermatologic preparation |
US5646186A (en) | 1994-05-17 | 1997-07-08 | Johnson & Johnson Consumer Products, Inc. | Retinoid composition |
US5424082A (en) | 1994-03-03 | 1995-06-13 | The Proctor & Gamble Company | Calcium and vitamin C containing beverage products with improved color stability |
EP0774907B1 (en) * | 1994-08-08 | 2000-12-27 | The Procter & Gamble Company | Color stable composition containing tea and fruit juice |
WO1996007396A2 (en) | 1994-09-07 | 1996-03-14 | Johnson & Johnson Consumer Products, Inc. | Retinoid compositions |
US5976555A (en) | 1994-09-07 | 1999-11-02 | Johnson & Johnson Consumer Products, Inc. | Topical oil-in-water emulsions containing retinoids |
CN1185729A (en) | 1995-04-03 | 1998-06-24 | 庄臣消费品有限公司 | Skin care compositions containing retinoids and liposomes |
FR2737971B1 (en) | 1995-08-25 | 1997-11-14 | Lvmh Rech | USE OF VITAMIN C OR DERIVATIVES OR THE LIKE TO STIMULATE SKIN ELASTINE SYNTHESIS |
FR2738742B1 (en) * | 1995-09-19 | 1997-11-14 | Oreal | USE OF AT LEAST ONE VICHY THERMAL WATER AS AN ANTAGONIST OF SUBSTANCE P |
US6139872A (en) * | 1996-08-14 | 2000-10-31 | Henkel Corporation | Method of producing a vitamin product |
US6099591A (en) * | 1998-01-29 | 2000-08-08 | Aveda Corporation | Method and composition for hair coloring using green tea polyphenols |
US6521237B2 (en) | 1998-11-12 | 2003-02-18 | Johnson & Johnson Consumer Companies, Inc. | Skin care composition |
-
2000
- 2000-06-02 US US09/586,583 patent/US6468552B1/en not_active Expired - Lifetime
-
2001
- 2001-06-01 EP EP01946035A patent/EP1289490A2/en not_active Ceased
- 2001-06-01 WO PCT/US2001/017739 patent/WO2001093816A2/en not_active Application Discontinuation
- 2001-06-01 AU AU2001268131A patent/AU2001268131A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2001093816A3 (en) | 2002-06-27 |
EP1289490A2 (en) | 2003-03-12 |
WO2001093816A2 (en) | 2001-12-13 |
US6468552B1 (en) | 2002-10-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001236457A1 (en) | Compounds and compositions for delivering active agents | |
AU2001283354A1 (en) | Compositions containing hypoglycemically active stilbenoids | |
AU2001284985A1 (en) | Compounds and compositions for delivering active agents | |
AU2002243277A1 (en) | Methods and compositions for encapsulating active agents | |
AU2001282877A1 (en) | Cosmetic compositions | |
AU2001295657A1 (en) | Formulation containing wax-esters | |
AU2001234509A1 (en) | Antimicrobial compositions | |
AU6103200A (en) | Perfume compositions | |
AU2002218751A1 (en) | Stable radiopharmaceutical compositions | |
AU2001265919A1 (en) | Cosmetic compositions | |
AU2001234114A1 (en) | Drugs containing combined active ingredients | |
AU2001268131A1 (en) | Stabilized compositions containing oxygen-labile active agents | |
AU2001288277A1 (en) | Compounds and compositions for delivering active agents | |
AU2001263839A1 (en) | Liquid formulations | |
AU2001248215A1 (en) | Cosmetically active composition | |
AUPQ875700A0 (en) | Combination compositions | |
AU2001268953A1 (en) | Antimicrobial compositions | |
AU2001272383A1 (en) | Fungicidal combinations of active agents | |
AU2001283569A1 (en) | Compositions containing hypotriglyceridemically active stilbenoids | |
AU2001294391A1 (en) | Coating compositions containing perfluoropolyether surfactants | |
AU2002357010A1 (en) | Stabilized active oxygen compositions | |
AU2002316200A1 (en) | Compound and composition for delivering active agents | |
AU4317500A (en) | Antibiral compositions containing phorbol derivatives as the main active ingredient | |
AU2001245615A1 (en) | Pouched composition | |
AU2001286996A1 (en) | Stabilized fgf formulations containing reducing agents |